Moclobemide affects pharmacokinetics of oral rizatriptan

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1999年 / 764卷 / 1期
关键词：
Placebo; Healthy Volunteer; Single Dose; Clinical Pharmacology; Monoamine;
D O I：
10.2165/00128415-199907640-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF ORAL CEPHALOSPORINS
    FINKELSTEIN, ER
    QUINTILIANI, R
    NIGHTINGALE, CH
    JOURNAL OF PEDIATRICS, 1978, 93 (05): : 902 - 902
  • [42] ORAL ACYCLOVIR PHARMACOKINETICS
    TRUE, BL
    CARTER, BL
    CLINICAL PHARMACY, 1985, 4 (04): : 372 - &
  • [43] Bioavailability Enhancement of Rizatriptan Benzoate by Oral Disintegrating Strip: In vitro and In vivo Evaluation
    Bhagawati, S. T.
    Chonkar, Ankita D.
    Dengale, Swapnil J.
    Reddy, Sreenivasa M.
    Bhat, Krishnamurthy
    CURRENT DRUG DELIVERY, 2016, 13 (03) : 462 - 470
  • [44] FAMOTIDINE AFFECTS THE PHARMACOKINETICS OF DICLOFENAC SODIUM
    SURYAKUMAR, J
    CHAKRAPANI, T
    KRISHNA, DR
    DRUG INVESTIGATION, 1992, 4 (01): : 66 - 68
  • [45] Silibinin affects the pharmacokinetics of methadone in rats
    Pan, Pei-Pei
    Wang, Jun
    Luo, Jun
    Wang, Shuang-Hu
    Zhou, Yun-Fang
    Chen, Sai-Zhen
    Du, Zhou
    DRUG TESTING AND ANALYSIS, 2018, 10 (03) : 557 - 561
  • [46] Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19.
    Yim, DS
    Yu, KS
    Cho, JY
    Park, SS
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P72 - P72
  • [47] LACK OF AN IMPORTANT INFLUENCE OF CYP2D6 OXIDATION STATUS ON THE PHARMACOKINETICS OF MOCLOBEMIDE
    GUENTERT, TW
    GRANGE, S
    BOCK, J
    WALDBURGER, R
    BIRNBOECK, H
    HOFFMANNLAROCHE, F
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 151 - 151
  • [48] Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19
    Yu, KS
    Yim, DS
    Cho, JY
    Park, SS
    Park, JY
    Lee, KH
    Jang, IJ
    Yi, SY
    Bae, KS
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (04) : 266 - 273
  • [49] Oral and IV oxymorphone clinical pharmacokinetics (PK) compared to those of oral oxycodone pharmacokinetics
    Vashi, V
    Nichols, T
    Mundin, G
    McIver, T
    Smith, K
    PHARMACOTHERAPY, 2004, 24 (10): : 1461 - 1461
  • [50] Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans
    Ng-Mak, D. S.
    Hu, X. H.
    Chen, Y.
    Ma, L.
    Solomon, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (07) : 1091 - +
12345